Independence Trust’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$2.53M Buy
26,193
+60
+0.2% +$5.66K 2.8% 14
2017
Q3
$2.32M Sell
26,133
-40
-0.2% -$3.04K 2.65% 16
2017
Q2
$1.9M Buy
26,173
+990
+4% +$66.6K 2.25% 17
2017
Q1
$1.64M Sell
25,183
-360
-1% -$22.6K 2.11% 18
2016
Q4
$1.6M Buy
25,543
+1,140
+5% +$69.6K 2.19% 17
2016
Q3
$1.54M Hold
24,403
2.52% 17
2016
Q2
$1.51M Sell
24,403
-520
-2% -$31.7K 2.32% 19
2016
Q1
$1.42M Buy
24,923
+290
+1% +$16.2K 2.24% 19
2015
Q4
$1.46M Sell
24,633
-10
-0% -$576 1.9% 19
2015
Q3
$1.34M Sell
24,643
-400
-2% -$26K 1.38% 21
2015
Q2
$1.68M Sell
25,043
-120
-0.5% -$7.83K 1.13% 22
2015
Q1
$1.47M Hold
25,163
0.93% 25
2014
Q4
$1.65M Hold
25,163
1% 24
2014
Q3
$1.45M Sell
25,163
-515
-2% -$28.6K 0.96% 24
2014
Q2
$1.45M Hold
25,678
0.93% 25
2014
Q1
$1.32M Hold
25,678
0.91% 25
2013
Q4
$1.36M Hold
25,678
0.93% 23
2013
Q3
$1.15M Sell
25,678
-170
-0.7% -$7.54K 0.85% 25
2013
Q2
$1.07M Buy
+25,848
New +$1.13M 0.77% 26

Other funds holding ABBV

Independence Trust's ABBV Position: Q4 2017 in Review

Independence Trust increased its AbbVie (ABBV) stake by 0.23% in Q4 2017, buying an estimated $5.66K and bringing the position to 26,193 shares worth $2.53M. The position accounts for 2.8% of the portfolio, ranked #14.

Independence Trust first reported a position in ABBV in Q2 2013 and has held it in 19 quarters since. 2,000 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

  • Independence Trust held 26,193 shares of AbbVie worth $2.53M as of Q4 2017.
  • Independence Trust bought 60 AbbVie shares in Q4 2017, an estimated $5.66K.
  • AbbVie made up 2.8% of Independence Trust's portfolio in Q4 2017, its #14 holding.
  • Independence Trust first reported a position in AbbVie in Q2 2013 and has held it in 19 quarters since.
  • 2,000 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on Independence Trust's 13F filing for Q4 2017, filed 8 Feb 2018.